Keith W. Crawford
- Virology top 5%
- HIV Research and Treatment 7
- Infectious Diseases top 10%
- HIV/AIDS Research and Interventions 8
- HIV/AIDS drug development and treatment 6
- Emergency Medicine top 10%
- HIV-related health complications and treatments 3
-
- Pharmacological Receptor Mechanisms and Effects 2
-
- HIV, Drug Use, Sexual Risk 2
-
- Pharmaceutical Practices and Patient Outcomes 2
-
- Ancient Egypt and Archaeology 2
- Co-authors
- Wayne D. BowenAndrew CoopC. E. ThomasE.A. FreyCharles FlexnerA. LevinDavid H. Brown RipinJoseph Fitzgibbon
- Journals
- The Journal of Infectious Diseases (1 paper)The Lancet Infectious Diseases (1 paper)Molecular Pharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomKenya
In The Last Decade
Keith W. Crawford
17 papers receiving 489 citations
Peers
Comparison fields: 5 of 82
- Virology 82
- Infectious Diseases 119
- Cellular and Molecular Neuroscience 115
- Emergency Medicine 57
- Biological Psychiatry 11
Countries citing papers authored by Keith W. Crawford
This map shows the geographic impact of Keith W. Crawford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith W. Crawford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith W. Crawford more than expected).
Fields of papers citing papers by Keith W. Crawford
This network shows the impact of papers produced by Keith W. Crawford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith W. Crawford. The network helps show where Keith W. Crawford may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keith W. Crawford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 1 | |
| 3 | 2018 | 8 | |
| 4 | 2017 | 11 | |
| 5 | 2017 | 5 | |
| 6 | 2017 | 24 | |
| 7 | 2014 | 3 | |
| 8 | 2014 | 8 | |
| 9 | 2013 | 26 | |
| 10 | 2012 | 31 | |
| 11 | 2010 | 29 | |
| 12 | 2010 | 9 | |
| 13 | 2002 | 69 | |
| 14 | Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. | 2002 | 211 |
| 15 | 1996 | 4 | |
| 16 | The Racial Identity of Ancient Egyptian Populations Based on the Analysis of Physical Remains | 1994 | 1 |
| 17 | 1993 | 13 | |
| 18 | 1992 | 38 | |
| 19 | 1982 | 1 |
About Keith W. Crawford
Keith W. Crawford is a scholar working on Virology, Geriatrics and Gerontology and Infectious Diseases, having authored 19 papers that have together received 493 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers), HIV-related health complications and treatments (3 papers), Pharmacological Receptor Mechanisms and Effects (2 papers), HIV, Drug Use, Sexual Risk (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Ancient Egypt and Archaeology (2 papers). The work is most often cited by research in Virology (82 citations), Infectious Diseases (119 citations) and Cellular and Molecular Neuroscience (115 citations). Keith W. Crawford has collaborated with scholars based in United States, United Kingdom and Kenya. Frequent co-authors include Wayne D. Bowen, Andrew Coop, C. E. Thomas, E.A. Frey, Charles Flexner, A. Levin, David H. Brown Ripin, Joseph Fitzgibbon, Alan Landay and Teresa L. Parsons. Their work appears in journals such as The Journal of Infectious Diseases, The Lancet Infectious Diseases and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.